It is an educational reference
Injectable weight loss medications in plastic surgery: what we know, perioperative considerations, and recommendations for the future
These differences help explain why GLP-1 drugs work best for people whose obesity is rooted in gut hormone dysfunction, while those with brain-based appetite signaling issues may respond better to older medications or drug combinations
Notably, in the context of the NF-B pathway, artemisinin not only inhibits NF-B expression by disrupting upstream cascades and/or directly binding to NF-B but also downregulates multiple downstream genes controlled by NF-B, including inflammatory chemokines and their receptors
[17] Papp LV, Lu J, Holmgren A, Khanna KK
Based on collective human data, a glycemic threshold of 99 108 mg/dL may exist, below which GIP primarily exerts glucagonotropic actions (35)